Drug Control Division

Licenses, Registrations, Permits, etc. - Find all of the types of Licenses, Registration, Permits that are a part of the Drug Control Division  and more.

Commission of Pharmacy - Find meeting minutes, members and other pharmacy related information and more.

Pharmacy Complaints - Learn how to file a complaint about a pharmacy.

Preventing Prescription/Medication Errors  - Find tips for protecting yourself against prescription/medication errors.

Prescription Monitoring Program - Find information about the Connecticut Prescription Monitoring and Reporting System and more.

Medical Marijuana Program - Registration, practitioners information, qualifying conditions, frequently asked questions and more.

Registrant Resources and Guidance Documents - Find documents that may be help for different disciplines regulated by the Drug Control Division.

Law Enforcement Resources - Find general information about medication, charges and more.

Statutes and Regulations - Find law information regarding the laws that pertain to the Drug Control Division.

Certificate of Free Sale - Click here for the certificate of free sale documents required by the Drug Control Division.

 

Latest News/Quick Resource

New: Controlled Substance Prescribing Guidance

New: Return of Prescription Drugs to Pharmacies

New:Epinephrine in Authorized Entities

Updated:Suspicious Order Monitoring

New: Naloxone at Higher Education

New: Designated Pharmacist Requirements for Sterile Pharmaceutical Preparation

Electronic Prescribing of Controlled Substances

New Laws

• Public Act 19-191 An Act Addressing Opioid Use
  • Section 1: Pharmacist Counseling
  • Section 3: Pharmacy Technician Delegate in the Connecticut Prescription Monitoring and Reporting System
  • Section 4: Suspicious Order Monitoring
  • Section 6: Pain Agreements/Care Plan for Treatment of Pain with Opioids for Greater than 12 weeks
  • Section 7: Naloxone at Institutions of Higher Education
• Public Act 19-19 An Act Concerning Epinephrine Auto Injectors (Effective From Passage)
• Public Act 19-177 An Act Making Changes to Department of Consumer Protection Enforcement Statutes
  • Section 28: Sterile Compounding
  • Section 29: Pharmacy to report legal action commenced by federal or state agency
  • Section 30: Classification of Connecticut Controlled Substances
  • Section 31: Marijuana Products Schedule Changes
• Public Act 19-98 An Act Concerning the Scope of Practice of Advanced Practice Registered Nurses
  • Section 22 and 23: Advanced practice registered nurses and collaborative drug therapy management
• Public Act 19-38 An Act Concerning Increasing the Penalties for Sale of Fentanyl
• Public Act 19-13 An Act Concerning the Sale of Cigarettes, Tobacco Products, Electronic Nicotine Delivery Systems and Vapor Products to Persons Under Age Twenty-One

• Public Act 18-166 (Effective 7/1/2018)
  • Section 2: Self and Family Prescribing of Controlled Substances Limitation
  • Section 3: Naloxone Distribution Agreements
•  Public Act 18-148 (Effective 7/1/18) 
  • Section 1: Telehealth - expansion to add controlled substances for a psychiatric disability or substance use disorder
  • Section 2: Prevents practitioners using telehealth from receiving a waiver from electronic prescribing of controlled substances
• Public Act 18-74 (Effective 10/1/2018) - Biologic products 
• Public Act 18-16 (Effective 1/1/19) 
  • Section 1: Penalty per violation of the chapter
  • Section 2: Fees for filing changes for Non-Resident Pharmacies
  • Section 3: Suspicious order reporting for Manufacturers and Wholesalers
  • Section 4: Annually controlled substance inventory
  • Section 5: Perpetual inventory for Schedule II medications with monthly reconciliation
  • Section 6: Sterile compounding 
• Public Act 17-131 An Act Preventing Prescription Opioid Diversion and Abuse
  • Section 1: Data Sharing
  • Section 2: Drug destruction 
  • Section 3: Electronic Prescribing of Controlled Substances
  • Section 4: Voluntary nonopioid directive form
  • Section 5: Prescribing of Opioids update
  • Section 6: Medication assisted treatment
  • Section 12: Naloxone standing order

• Public Act No. 16-43 An Act Concerning Opioids and Access to Overdose Reversal Drugs.
  • Section 1: Naloxone prescribing, dispensing and administration update
  • Section 7: Prescribing of Opioids (7 day limit)
  • Section 8: Agent of the prescriber (Prescription Monitoring Program) 
  • Section 9: Prescription Monitoring Program (daily reporting, veterinary uploads, agent of the prescriber)
• Manufacturer APRN Expenditure Reporting
• Medical Marijuana FAQs
• Ban on the Sale of Synthetic Drug Products
• Retailer Advisory on the Sale of Imported Food and Drug Products
• Brochure: Medication Drop-Box Program
• Towns with Prescription Drop Boxes
• Proper Disposal of Prescription Medication
• Guidance letter for the Act Concerning the Storage and Administration of Epinephrine at Public Schools

• HYDROCODONE MOVES TO SCHEDULE II
  • Prescriptions issued before October 6, 2014:   October 6, 2014/April 8, 2015 :  Any prescriptions for HCPs that are issued before October 6, 2014, and authorized for refilling, may be dispensed in accordance with 21 CFR 1306.22-1306.23, 1306.25, and 1306.27, if such dispensing occurs before April 8, 2015.
  • Prescriptions issued on or after October 6, 2014 :  October 6: 2014 :  No prescription for HCPs issued on or after October 6, 2014 shall authorize any refills. 

• Prescription Drug: Misuse and Abuse